221 related articles for article (PubMed ID: 11720009)
1. Matrix metalloproteinase and cytokine profiles in monocytes over the course of stroke.
Kouwenhoven M; Carlström C; Ozenci V; Link H
J Clin Immunol; 2001 Sep; 21(5):365-75. PubMed ID: 11720009
[TBL] [Abstract][Full Text] [Related]
2. Multiple sclerosis: elevated expression of matrix metalloproteinases in blood monocytes.
Kouwenhoven M; Ozenci V; Gomes A; Yarilin D; Giedraitis V; Press R; Link H
J Autoimmun; 2001 Jun; 16(4):463-70. PubMed ID: 11437495
[TBL] [Abstract][Full Text] [Related]
3. Monocyte-derived dendritic cells express and secrete matrix-degrading metalloproteinases and their inhibitors and are imbalanced in multiple sclerosis.
Kouwenhoven M; Ozenci V; Tjernlund A; Pashenkov M; Homman M; Press R; Link H
J Neuroimmunol; 2002 May; 126(1-2):161-71. PubMed ID: 12020967
[TBL] [Abstract][Full Text] [Related]
4. Expression profile of matrix metalloproteinase-2 and -9 and their endogenous tissue inhibitors in osteonecrotic femoral heads.
Grässel S; Beckmann J; Rath B; Vogel M; Grifka J; Tingart M
Int J Mol Med; 2010 Jul; 26(1):127-33. PubMed ID: 20514432
[TBL] [Abstract][Full Text] [Related]
5. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human optic nerve head astrocytes.
Agapova OA; Ricard CS; Salvador-Silva M; Hernandez MR
Glia; 2001 Mar; 33(3):205-16. PubMed ID: 11241738
[TBL] [Abstract][Full Text] [Related]
6. Multiple sclerosis: pro- and anti-inflammatory cytokines and metalloproteinases are affected differentially by treatment with IFN-beta.
Ozenci V; Kouwenhoven M; Teleshova N; Pashenkov M; Fredrikson S; Link H
J Neuroimmunol; 2000 Aug; 108(1-2):236-43. PubMed ID: 10900359
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinase expression and activity following prostaglandin F(2 alpha)-induced luteolysis.
Ricke WA; Smith GW; Smith MF
Biol Reprod; 2002 Mar; 66(3):685-91. PubMed ID: 11870075
[TBL] [Abstract][Full Text] [Related]
8. Expression of interleukin-1 beta, tumor necrosis factor alpha, interleukins-6, -10 and -4, and metalloproteases by freshly isolated mononuclear cells from early never-treated and non-acute treated rheumatoid arthritis patients.
Vázquez-Del Mercado M; Delgado-Rizo V; Muñoz-Valle JF; Orozco-Alcalá J; Volk HD; Armendáriz-Borunda J
Clin Exp Rheumatol; 1999; 17(5):575-83. PubMed ID: 10544841
[TBL] [Abstract][Full Text] [Related]
9. Metalloproteinase and inhibitor expression profiling of resorbing cartilage reveals pro-collagenase activation as a critical step for collagenolysis.
Milner JM; Rowan AD; Cawston TE; Young DA
Arthritis Res Ther; 2006; 8(5):R142. PubMed ID: 16919164
[TBL] [Abstract][Full Text] [Related]
10. Time-course and muscle-specific gene expression of matrix metalloproteinases and inflammatory cytokines in response to acute treadmill exercise in rats.
Turkel I; Tahtalioglu S; Celik E; Yazgan B; Kubat GB; Ozerklig B; Kosar SN
Mol Biol Rep; 2024 May; 51(1):667. PubMed ID: 38780696
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinases and their tissue inhibitors as markers of disease subtype and response to interferon-beta therapy in relapsing and secondary-progressive multiple sclerosis patients.
Galboiz Y; Shapiro S; Lahat N; Rawashdeh H; Miller A
Ann Neurol; 2001 Oct; 50(4):443-51. PubMed ID: 11601495
[TBL] [Abstract][Full Text] [Related]
12. Dynamic expression of mRNAs and proteins for matrix metalloproteinases and their tissue inhibitors in the primate corpus luteum during the menstrual cycle.
Young KA; Hennebold JD; Stouffer RL
Mol Hum Reprod; 2002 Sep; 8(9):833-40. PubMed ID: 12200461
[TBL] [Abstract][Full Text] [Related]
13. MMPs contribute to TNF-alpha-induced alteration of the blood-cerebrospinal fluid barrier in vitro.
Zeni P; Doepker E; Schulze-Topphoff U; Huewel S; Tenenbaum T; Galla HJ
Am J Physiol Cell Physiol; 2007 Sep; 293(3):C855-64. PubMed ID: 17507431
[TBL] [Abstract][Full Text] [Related]
14. Differential expression profiling of matrix metalloproteinases and tissue inhibitors of metalloproteinases in females with or without pelvic organ prolapse.
Wang X; Li Y; Chen J; Guo X; Guan H; Li C
Mol Med Rep; 2014 Oct; 10(4):2004-8. PubMed ID: 25110112
[TBL] [Abstract][Full Text] [Related]
15. mRNA levels of membrane-type 1 matrix metalloproteinase (MT1-MMP), MMP-2, and MMP-9 and of their inhibitors TIMP-2 and TIMP-3 in normal thyrocytes and thyroid carcinoma cell lines.
Hofmann A; Laue S; Rost AK; Scherbaum WA; Aust G
Thyroid; 1998 Mar; 8(3):203-14. PubMed ID: 9545106
[TBL] [Abstract][Full Text] [Related]
16. Induction of dental pulp fibroblast matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 gene expression by interleukin-1alpha and tumor necrosis factor-alpha through a prostaglandin-dependent pathway.
Lin SK; Wang CC; Huang S; Lee JJ; Chiang CP; Lan WH; Hong CY
J Endod; 2001 Mar; 27(3):185-9. PubMed ID: 11487149
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-17 and Tumor Necrosis Factor Show a Functional Hierarchy to Regulate the Production of Matrix Metalloproteases by Monocytes from Patients with Psoriasis.
Springall R; Ortega-Springall MF; Guerrero-Ponce AE; Vega-Memije ME; Amezcua-Guerra LM
J Interferon Cytokine Res; 2023 Mar; 43(3):140-146. PubMed ID: 36939813
[TBL] [Abstract][Full Text] [Related]
18. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].
Hu XX; Li L; Li DR; Zhang W; Cheng XQ; Zhang JQ; Tang BJ
Ai Zheng; 2004 Oct; 23(10):1194-8. PubMed ID: 15473934
[TBL] [Abstract][Full Text] [Related]
19. Metalloproteinases and their tissue inhibitors in multiple sclerosis.
Ozenci V; Rinaldi L; Teleshova N; Matusevicius D; Kivisäkk P; Kouwenhoven M; Link H
J Autoimmun; 1999 Jun; 12(4):297-303. PubMed ID: 10330301
[TBL] [Abstract][Full Text] [Related]
20. Expression of tissue levels of matrix metalloproteinases and their inhibitors in breast cancer.
Zhang M; Teng XD; Guo XX; Li ZG; Han JG; Yao L
Breast; 2013 Jun; 22(3):330-4. PubMed ID: 22995648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
